Analysis of the NH2‐Terminal 83rd Amino Acid of Escherichia coli GyrA in Quinolone‐Resistance
- 1 April 1995
- journal article
- Published by Wiley in Microbiology and Immunology
- Vol. 39 (4) , 243-247
- https://doi.org/10.1111/j.1348-0421.1995.tb02196.x
Abstract
Artificial mutations of Gyrase A protein (GyrA) in Escherichia coli by site-directed mutagenesis were generated to analyze quinolone-resistant mechanisms. By genetic analysis of gyrA genes in a gyrA temperature sensitive (Ts) background, exchange of Ser at the NH2-terminal 83rd position of GyrA to Trp, Leu, Phe, Tyr, Ala, Val, and Ile caused bacterial resistance to the quinolones, while exchange to Gly, Asn, Lys, Arg and Asp did not confer resistance. These results indicate that it is the most important for the 83rd amino acid residue to be hydrophobic in expressing the phenotype of resistance to the quinolones. These findings also suggest that the hydroxyl group of Ser would not play a major role in the quinolone-gyrase interaction and Ser83 would not interact directly with other amino acid residues.Keywords
This publication has 17 references indexed in Scilit:
- Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acidAntimicrobial Agents and Chemotherapy, 1993
- Mechanisms of Resistance to QuinolonesDrugs, 1993
- The molecular basis of quinolone actionJournal of Antimicrobial Chemotherapy, 1992
- Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coliAntimicrobial Agents and Chemotherapy, 1991
- Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coliAntimicrobial Agents and Chemotherapy, 1990
- gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coliAntimicrobial Agents and Chemotherapy, 1989
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1985
- DNA TopoisomerasesAnnual Review of Biochemistry, 1981
- Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencingJournal of Molecular Biology, 1980
- Mode of Incomplete Cross-Resistance Among Pipemidic, Piromidic, and Nalidixic AcidsAntimicrobial Agents and Chemotherapy, 1978